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Abstract 21 
 22 
Study question: Are women with endometriosis who conceive with IVF at increased risk of 23 
preterm birth?  24 
Summary answer: Women with endometriosis who conceive with IVF do not face an increased 25 
risk of preterm birth.  26 
What is known already: The eutopic endometrium of women with endometriosis has been 27 
repeatedly shown to present molecular and cellular alterations. On this basis, it has been 28 
hypothesized that pregnancy outcome may be altered in affected women. However, to date, 29 
available evidence from epidemiological studies is scanty and conflicting. Data tended to be partly 30 
consistent only for an increased risk of preterm birth and placenta previa. 31 
Study design, size, duration: Retrospective matched case-control study of women achieving an 32 
IVF singleton pregnancy progressing beyond 12 weeks’ gestation.  33 
Participants/materials, setting, methods: Women achieving IVF singleton pregnancies that 34 
progressed beyond 12 weeks’ gestation at two infertility units were reviewed. Cases were women 35 
with a history of surgery for endometriosis and/or with a sonographic diagnosis of the disease at the 36 
time of the IVF cycle. Controls were women without current or past evidence of endometriosis who 37 
were matched to cases by age (± 6 months), type of cycle (fresh or frozen cycle) and study period. 38 
Male factor and unexplained infertility were the most common diagnoses in the control group. Two 39 
hundred and thirty-nine women with endometriosis and 239 controls were selected. The main 40 
outcome of the study was the rate of preterm birth (birth < 37 weeks’ gestation) regardless of the 41 
cause. Secondary analyses were performed for the most common obstetrical complications. 42 
Main results and the role of chance: The rate of preterm birth was similar in the two study groups 43 
(14% and 14%, respectively, p=0.89). The rate of live birth and the incidence of hypertensive 44 
disorders, gestational diabetes, small and large for gestational age newborns and neonatal problems 45 
also did not differ. In contrast, placenta previa was more common in women with endometriosis 46 
than controls (6% versus 1%, respectively; p=0.006): The adjusted odds ratio was 4.8 (95% 47 
confidence interval: 1.4-17.2).  48 
Limitations, reasons for caution: As for all observational studies, confounders cannot be totally 49 
excluded. Moreover, the retrospective study design exposes the findings to some inaccuracies. For 50 
example, the independent role of adenomyosis could not be reliably assessed because this diagnosis 51 
is complex and would necessitate a prospective recruitment. Second, the selection of controls may 52 
also be a matter of concern because some affected women may have been erroneously included in 53 
this group. Third, even if the sample size is significant, it is insufficient for robust subgroup 54 
analyses. Finally, it is mandatory to point out that our conclusions are valid for IVF pregnancies 55 
only, andspecific data from properly designed studies are required to support any inference for 56 
natural pregnancies.   57 
Wider implications of the findings: The results of our study suggest that women with 58 
endometriosis conceiving with IVF can be reassured regarding the risk of preterm birth. The 59 
observed association with placenta previa requires further investigation and may open a new avenue 60 
of research.  61 
Study funding/competing interest: No external funding was used for this study. None of the 62 
authors have any conflict of interest to declare. 63 
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Introduction 68 
 69 
There is robust biological evidence showing that the endometrium of women with endometriosis 70 
differs from the endometrium of healthy unaffected women. Differences have been found in stem 71 
cell content, hormone sensitivity, cellular proliferation, adhesion, invasiveness, angiogenesis and 72 
immune modulation (May et al., 2011; Benagiano et al., 2014; Vercellini et al., 2014). Moreover, 73 
the endometrium of women with endometriosis was shown to be resistant to selective actions of 74 
progesterone, a hormone that affects decidualization and modulates the local inflammatory process 75 
during implantation (Burney et al., 2007, Benagiano et al., 2014). Noteworthy, there is also 76 
accumulating evidence suggesting that complications occurring during the second and third 77 
trimester of pregnancy, such as pregnancy-related hypertensive disorders or reduced fetal growth, 78 
may actually originate from local disturbances occurring at the time of implantation (Sharkey et al. 79 
2013; Chaiworapongsa et al. 2014; Hsu et al. 2014). 80 
On this basis, it has been hypothesized that pregnancy outcome may be altered in women with 81 
endometriosis. However, to date, available evidence is scanty and conflicting (Brosens et al. 2007; 82 
Stephansson et al. 2009; Fernando et al. 2009; Hadfield et al. 2009; Benaglia et al. 2012; Vercellini 83 
et al. 2012; Conti et al. 2015; Mekaru et al. 2014; Stern et al., 2015). The validity of most of these 84 
studies is actually hampered by methodological limitations, insufficient sample size or diagnostic 85 
inaccuracies (Viganò et al., 2015; Leone Roberti Maggiore et al., 2016). Two recent systematic 86 
reviews of the literature failed to draw definite conclusions on the relation between endometriosis 87 
and obstetrical complications. The data tended to be consistent only for an increased risk of preterm 88 
birth and placenta previa (Viganò et al., 2015; Leone Roberti Maggiore et al., 2016).  89 
In order to shed more light on this debated and intriguing issue, we set up a two-center study to 90 
evaluate pregnancy outcomes in IVF singleton pregnancies. In order to overcome the limitations of 91 
previous studies, controls were singleton IVF pregnancies matched to cases by age, type of cycle 92 
(fresh or frozen) and study period. The recruitment of cases and controls from the same population, 93 
the matching design and the use of an active individualized follow-up rather than data from national 94 
registries were expected to overcome most of the limitations of previous studies. 95 
 96 
 97 
Materials and Methods 98 
 99 
Women undergoing IVF at the infertility unit of the Fondazione Ca’ Granda, Ospedale Maggiore 100 
Policlinico of Milan, Italy (between January 2008 and June 2014) and at the infertility unit of the 101 
San Raffaele Scientific Institute of Milan, Italy (between January 2009 and June 2014) were 102 
retrospectively reviewed. Inclusion criteria were as follows: age 18-42 years; classical IVF or ICSI 103 
cycles (fresh or frozen); clinical singleton pregnancy progressing beyond 12 weeks’ gestation; 104 
follow-up available up to the end of pregnancy (by law, infertility units in Italy are requested to 105 
actively investigate pregnancy outcome of IVF pregnancies). A questionnaire aimed at collecting 106 
pregnancy and neonatal outcome and complications was systematically used in both centres. 107 
Exclusion criteria included: uterine malformations (such as, in particular, septate uterus); intramural 108 
fibroids; multiple pregnancy at first ultrasound assessment performed at 7 weeks’ gestation (women 109 
with a vanishing twin were thus excluded); 4) major pathological conditions with possible impact 110 
on pregnancy course such as pre-pregnancy diabetes, previous organ transplantation, 111 
antiphospholipid syndrome, chronic renal diseases, systemic lupus erythematosus, and pre-112 
pregnancy hypertension. Thyroid disorders were not an exclusion criteria but, in the two centres all 113 
women were requested to have a serum thyroid-stimulating hormone test and, if thyroid disorders 114 
emerged, they had to normalize thyroid function before starting the cycle. Women could be 115 
included only for the first IVF cycle ending in a clinical pregnancy progressing beyond 12 weeks’ 116 
gestation. Conversely, there was no restriction on  the number of previous failed cycles. 117 
Cases were women with a history of surgery for endometriosis and those in whom ovarian 118 
endometriomas were identified at the time of the IVF cycle. Controls were matched to cases on a 119 
1:1 ratio by age (± 6 months), type of cycle (fresh or frozen cycle) and study period (the next 120 
woman fulfilling the criteria for selection and matching). Women without a history of surgery for 121 
endometriosis but who were diagnosed with soft markers of the disease or suspected deep nodules 122 
(Guerriero et al., 2016) were excluded from both cases and controls.  123 
The institutional review boards of the two participating hospitals approved the study. An informed 124 
consent was not required as this is a retrospective study. However, all women aattending the two 125 
centres are requested to sign an informed consent for their data to be used for scientific purposes 126 
and agree to be contacted after the procedure for follow-up. Women who denied this consent were 127 
excluded. 128 
The diagnosis of endometrioma was by transvaginal ultrasound according to  established criteria 129 
(Savelli, 2009) and had to be documented on at least two occasions and at least two menstrual 130 
cycles apart. Women with a history of surgery for endometriosis were routinely requested to 131 
provide documentation of the intervention in order to obtain a surgical description and histological 132 
confirmation.  133 
Women undergoing IVF followed standardized protocols that are reported in detail elsewhere 134 
(Benaglia et al., 2014; Papaleo et al., 2014). Embryo transfer was performed 48-72 hours after 135 
oocyte collection or, in selected subjects, at the blastocyst stage. In fresh cycles, vaginal 136 
progesterone was given for 2 weeks after the oocytes retrieval. In frozen cycles, women receiving 137 
hormone replacement therapy (HRT) continued the therapy for the whole first trimester of 138 
pregnancy. HRT consisted of oral estradiol valerate 4-6 mg daily and subsequently vaginal 139 
progesterone 600 mg daily. Women undergoing frozen embryo transfer in a natural cycle did not 140 
receive any therapeutic support. 141 
Clinical data were recovered from clinical charts, including pregnancy follow-up information. If 142 
inconsistencies emerged or if data were incomplete, the obstetrical charts were consulted and, if 143 
doubts persisted, women were contacted for clarifications.  144 
Information that was actively sought at the time of follow-up included gestational age at the end of 145 
pregnancy, hypertensive disorders developing during pregnancy or during puerperium, diagnosis of 146 
gestational diabetes, diagnosis of placental disorders, mode of delivery and, if applicable, indication 147 
for labour induction or caesarean delivery, neonatal sex and weight, viability and health conditions 148 
of the newborn including malformations and neonatal intensive care unit admission. Small for 149 
gestational age (SGA) and large for gestational age (LGA) were defined as a newborn weight < 10 150 
centile and > 90 centile, respectively. Centiles were determined using the local referral values 151 
(Parazzini et al., 1991). Pre-eclampsia was defined as the concomitant presence of hypertension and 152 
significant amounts of protein in the urine (Mol et al., 2015). Hypertension in the absence of 153 
proteinuria was defined as pregnancy-induced hypertension. 154 
The main outcome used to calculate the sample size was the rate of preterm birth (birth < 37 weeks’ 155 
gestation) regardless of the cause. More specifically, we calculated the sample size setting type I 156 
and II errors at 0.05 and 0.20, respectively, postulating a rate of preterm birth in unexposed women 157 
of 10% and claiming as clinically relevant a two-fold increased risk of preterm birth (from 10% to 158 
20%). On this basis, the number of women to be recruited was at least 200 per group. Data were 159 
analyzed using the Statistical Package for the Social Sciences software 18.0 (Chicago, IL, USA). 160 
The Fisher’s Exact test, Student’s t-test and Wilcoxon nonparametric test were used, as appropriate. 161 
P values below 0.05 were considered statistically significant. A logistic regression model including 162 
baseline variables found to significantly differ between the two groups was used to calculate the 163 
adjusted odds ratio (OR) of variables found to significantly differ at univariate analysis.  164 
 165 
 166 
Results 167 
 168 
We ultimately selected 239 women with endometriosis and 239 unexposed controls. Among cases, 169 
a previous history of surgery for endometriosis was reported by 186 women (78%). The remaining 170 
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53 (22%) had an ultrasound diagnosis of endometriomas and did not undergo previous surgery for 171 
the disease. Specific characteristics of the affected women are shown in Table 1. Baseline 172 
characteristics of the two study groups are summarized in Table 2. A statistically significant 173 
difference was found for BMI, duration of infertility and indication to treatment. Male factor 174 
infertility and unexplained infertility were the two most common diagnoses in the control group. 175 
One-hundred and eighty-seven cases and 187 controls achieved pregnancy during a fresh cycle. 176 
Characteristics of these fresh cycles are illustrated in Table 3. Women with endometriosis had 177 
slightly fewer oocytes retrieved. Table 4 shows the characteristics of the frozen cycles (52 per 178 
group), none of which differed between groups.  179 
Pregnancy outcomes in the two groups are illustrated in Table 5. The rate of preterm birth was 180 
similar: The crude OR was 1.15 (95% confidence interval (CI): 0.60-2.17), while the OR adjusted 181 
for BMI and duration of infertility was 1.14 (95%CI: 0.58-2.22). Moreover, the incidence of live 182 
birth, hypertensive disorders, gestational diabetes, SGA, LGA and neonatal problems did not also 183 
differ. In contrast, we observed a statistically significant increase in the frequency of placenta previa 184 
in women with endometriosis (6% versus 1% in controls; p=0.006). The crude OR of placenta 185 
previa in women with endometriosis was 5.1 (95%CI: 1.4-17.8) and the OR adjusted for BMI and 186 
duration of infertility was 4.8 (95%CI: 1.4-17.2, p=0.015).  187 
Analyses for the primary outcome (preterm birth) in different subgroups of women with 188 
endometriosis are presented in Supplementary Table 1. No significant differences among groups 189 
emerged. Finally, all the analyses were repeated excluding unexposed women with a diagnosis of 190 
unexplained infertility, and including only women with a histologically confirmed diagnosis of 191 
endometriosis: The results were largely similar (detailed analyses not shown).  192 
 193 
 194 
 195 
 196 
Discussion 197 
 198 
Results from this observational study of IVF singleton pregnancies did not confirm an increased 199 
risk of preterm birth in women with endometriosis. We also failed to observe an increased risk of 200 
the other major obstetrical complications with the exception of placenta previa. Indeed, women with 201 
endometriosis have an increased risk of this complication, the adjusted OR being 4.8 (95%CI: 1.4-202 
17.2).  203 
The lack of any association between endometriosis and preterm birth (the primary aim of the study) 204 
is only partly surprising. Even if the available evidence generally tends to support a possible link 205 
(Vigano et al., 2015: Leone Roberti Maggiore et al., 2016), results were not univocal and the 206 
magnitude of the detected associations was in general too modest to support causality (Grimes and 207 
Schultz, 2012). Two main studies using national registries from Australia and Sweden initially 208 
supported a relation between endometriosis and preterm birth (Stephenson et al., 2009; Fernando et 209 
al., 2009). However, in the Australian study, this association was statistically significant only in the 210 
subgroup analysis that compared the group of ART-pregnancies obtained in women with 211 
endometriomas to the group of natural pregnancies in fertile women (Fernando et al., 2009). The 212 
Swedish study showed a statistically significant association for the whole group of affected women 213 
but the magnitude was modest (OR=1.3, 95%CI: 1.2-1.4) (Stephenson et al., 2009). Subsequent 214 
studies showed either an increased (Kuivassari-Pirinen et al., 2012; Conti et al., 2015; Stern et al., 215 
2015; Lin et al., 2015) or unchanged risk (Benaglia et al., 2012; Mekaru  et al., 2014). Noteworthy 216 
is that the OR exceeded 3 in only one study (Kuivassari-Pirinen et al., 2012). As recently 217 
emphasized by Grimes and Schulz (2012), ORs below 3 should not be considered credible. The 218 
presence of confounders, rather than causality, is the main explanation of such findings. Based also 219 
on the negative findings emerging from our study, a causal association between endometriosis and 220 
preterm birth appears unlikely. 221 
The observation of an association between endometriosis and placenta previa is intriguing but not 222 
novel. Some recent epidemiological studies actually supported this possibility (Vigano et al., 2015: 223 
Leone Roberti Maggiore et al., 2016). However, the study designs were in some cases debatable, 224 
the estimated magnitude varied widely and the 95%CI are in most cases very large. In the large 225 
Swedish study using national registers, Stephensson et al. observed that women with endometriosis 226 
had a higher risk of placental complications in general. However, the magnitude of the association 227 
(OR=1.8, 95%CI: 1.6-2.0) was less remarkable than the one observed in our study, probably 228 
because of a diluting effect (Stephenson et al., 2009). Two retrospective cohort studies comparing 229 
pregnancy outcomes of ART singleton pregnancies with those of natural pregnancies found higher 230 
rates of placenta previa in the ART groups, and showed by subgroup analyses that this risk was 231 
particularly evident for women requiring ART for endometriosis (Kuivassari-Pirinen et al., 2012; 232 
Healy et al. 2010). The adjusted OR was 1.7 (95%CI: 1.2-2.3) (Healy et al. 2010). A Japanese 233 
retrospective analysis aimed at identifying risk factors for placental abnormalities showed a strong 234 
positive association with endometriosis (OR=15.1, 95%CI: 7.6-500) (Takemura et al., 2013). 235 
Finally, a recent retrospective cohort study comparing the outcome of singleton natural pregnancies 236 
between women with and without endometriosis confirmed the higher risk of placenta previa in the 237 
affected women (adjusted OR=4.5, 95%CI: 1.2-16.5) (Lin et al., 2015).  238 
In the past, significant associations between endometriosis and obstetrical complications were 239 
seldom suggested in the literature. A striking protective effect of endometriosis towards pre-240 
eclampsia was claimed by Brosens et al. (2007). Unaffected women had an OR of pre-eclampsia of 241 
7.5 (95%CI: 1.7-33.3). Subsequent studies (Hadfield et al., 2009; Vercellini et al., 2012; Conti et 242 
al., 2015; Mekaru et al., 2014; Stern et al., 2015; Kuivassari-Pirinen et al., 2012; Lin et al., 2015; 243 
Aris, 2014) failed to confirm these findings. Stephenson et al. (2009) even detected an increased 244 
risk of pre-eclampsia in women with endometriosis  (OR=1.1, 95%CI:1.0-1.3). On the basis of 245 
these findings, the two available systematic reviews tended to conclude that no association between 246 
endometriosis and pre-eclampsia actually exists (Vigano et al., 2015: Leone Roberti Maggiore et 247 
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al., 2016). Our data are in line with this statement. Similar conclusions can be drawn for all the 248 
other obstetrical and neonatal complications investigated in our study (Vigano et al., 2015: Leone 249 
Roberti Maggiore et al., 2016). 250 
Some main limitations and strengths of this study deserve to be mentioned. First, our study is 251 
retrospective. This study design exposes our findings to some inaccuracies. For instance, we could 252 
not perform subgroup analyses according to the presence/absence of deep peritoneal lesions or 253 
adenomyosis. These types of lesion can be reliably identified with transvaginal ultrasound 254 
(Exacoustos et al., 2014; Guerriero et al., 2016), but this requires an active approach and utmost 255 
expertise. These lesions were seldom reported in the charts but, given our retrospective study 256 
design, we estimated that performing analyses based on these findings could lead to unreliable 257 
results. Further studies are thus required to disentangle this aspect. On the other hand, inaccuracies 258 
in the selection of cases is unlikely. The diagnosis of operated cases is unquestionable. For non-259 
operated cases, the exclusive inclusion of those with ovarian endometriomas (an easy and reliable 260 
sonographic diagnosis) protects our findings from relevant confounders. Of note, non-operated 261 
women with this form of the disease represented a minority of the included cases and a secondary 262 
analyses excluding these women led to similar results. Selection of the controls may, however, be a 263 
matter of concern. Controls did not undergo laparoscopy prior to IVF and, despite a suspected 264 
diagnosis of endometriosis being an exclusion criterion in our study, we cannot totally exclude the 265 
possibility that we erroneously selected some affected women. The inclusion of a relevant 266 
proportion of women with unexplained infertility (36%) among the controls supports this concern. 267 
However, the impact of this inaccuracy may be of limited relevance. First, the frequency of 268 
undetected endometriosis in women with an evident cause of infertility, such as pelvic 269 
inflammatory disease or male infertility (64% of our cohort of unexposed controls), can be 270 
postulated to be low (<10%), thus similar to the one observed in the general population (<10%) 271 
(Holt and Weiss, 2000; Zondervan et al., 2002). Conversely, in the remaining group of women with 272 
unexplained infertility, one has to expect that the condition has not been detected clinically in one-273 Formattato: Colore carattere:
Automatico
third to one-half of the women (Vercellini et al., 2009). Even if this proportion is more troublesome, 274 
it has to be pointed out that the severity of the disease in these undetected cases is expected to be 275 
minimal-mild in most of them. Finally, it is noteworthy that the exclusion (from both cases and 276 
controls) of women who were exclusively found with soft markers of the disease) and/or suspected 277 
nodules may have limited the risk of misclassification.  278 
Second, some basal characteristics of the two groups differed (BMI, duration of infertility and 279 
number of oocytes retrieved were lower among cases) and we cannot fully exclude an influence of 280 
confounders. BMI in particular may be of relevance because it may affect independently pregnancy 281 
outcome. However, detected differences were modest and of doubtful clinical relevance. Of note, is 282 
that the mean BMI was 21-22 Kg/m
2
, thus within the normal range for both study groups. The 283 
differences in duration of infertility and the number of oocytes retrieved are unlikely to bias our 284 
results considering that they were small and that there is no biological rationale to postulate a 285 
significant impact on pregnancy outcome. Moreover, the use of a logistic regression analysis may 286 
have further lessened the impact of the confounders. Noteworthy, the decision to select both cases 287 
and controls from IVF singleton pregnancies and the matching for age, type of cycle and study 288 
period will help to protect our data from other main confounders. This study design was not 289 
previously used and, in our opinion, it represents a main strength of our contribution.  290 
Third, even if the sample size is considerable, it is insufficient for robust subgroup analyses. In this 291 
regard, it has to be recognized that, even if based on national register analyses and thus exposed to 292 
inaccuracies, some of the previous studies presented data from larger sample sizes (Fernando et al., 293 
2009; Hadfield et al., 2009). This limitation should also be kept in mind when considering the 294 
detected association with placenta previa. Albeit the OR was considerable (4.8), the 95%CI was 295 
extremely large (from 1.4 to 17.2) and the statistical power for placenta previa calculated a 296 
posteriori was 78%. As a matter of fact, the lower limit falls into the previously discussed area of 297 
associations (<3) that could be explained by confounders (Grimes and Schulz, 2012). Disentangling 298 
the possible causal relation between endometriosis and placenta previa thus requires further 299 
evidence from specifically designed and properly powered studies.  300 
Finally, it is mandatory to point out that our conclusions are valid for IVF pregnancies only. Even if 301 
one may be tempted to speculate that our results may be valid for natural pregnancies, specific data 302 
from properly designed studies are warranted to support this inference.   303 
In conclusion, women with endometriosis do not face an increased risk of preterm birth. However, 304 
they may be exposed to an increased risk of placenta previa. Further evidence is warranted to 305 
explore this latter intriguing association. 306 
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